 "Take Solutions establishes life sciences firm Navitas")
Take Solutions Ltd, a global business technology solutions provider, has established Navitas, a pure-play life sciences solutions company, by bringing together the proven expert teams of Take Life Sciences and WCI Consulting, the UK-based consulting firm that was acquired by Take Solutions in January 2011.
Navitas has been created within Take Solutions to stand as a differentiated entity offering niche solutions for the pharma/biotech industry. The restructuring of the business is an integral part of Take’s go-to-market strategy to meet multiple objectives such as catering to the regulatory demands of clients and creating a more efficient organisation which can focus on innovation.
The capabilities of the new life sciences arm of Take Solutions covers industry leading networks, strategic & change management consulting, technology and services which are focused on the clinical, regulatory, safety and compliance domains. The new pure-play life sciences solutions company will cater to clients ranging in size and complexity.
Srinivasan H R, vice chairman and managing director, Take Solutions & chairman, Navitas, said, “There is a demand in the global pharma/life sciences market for regulatory compliance and customised solutions to meet business needs. The total addressable market of the lfe science industry is valued at $ 15.9 billion. Our move to create a new brand is to meet the demand of this market in time to emerge as a competent and differentiated player.”
Navitas has been created within Take Solutions to stand as a differentiated entity offering niche solutions for the pharma/biotech industry. The restructuring of the business is an integral part of Take’s go-to-market strategy to meet multiple objectives such as catering to the regulatory demands of clients and creating a more efficient organisation which can focus on innovation.
The capabilities of the new life sciences arm of Take Solutions covers industry leading networks, strategic & change management consulting, technology and services which are focused on the clinical, regulatory, safety and compliance domains. The new pure-play life sciences solutions company will cater to clients ranging in size and complexity.
Srinivasan H R, vice chairman and managing director, Take Solutions & chairman, Navitas, said, “There is a demand in the global pharma/life sciences market for regulatory compliance and customised solutions to meet business needs. The total addressable market of the lfe science industry is valued at $ 15.9 billion. Our move to create a new brand is to meet the demand of this market in time to emerge as a competent and differentiated player.”